Embed Size (px)
DESCRIPTION
For the complete report ,visit us at: bit.ly/market-research-india-pharmapoint-forecast Or, get in touch with us at : [email protected]
Citation preview
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
Category: Healthcare
www.researchonglobalmarkets.com
www.researchonglobalmarkets.com
• Publish date: Jun 30, 2013
• Number of slides: 131
• Geographic coverage: India
• Available format: PDF, CD, Hardcopy
• Price for Single User License: USD 4,995
• Price for Site License: USD 9,990
• Price for Global User License: USD 14,985
• Delivery Time: Within 1 business day
• Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google
Wallet, PayPal
Report Details
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
• Overview of non-small cell lung cancer (NSCLC) including
epidemiology, etiology, symptoms, diagnosis, pathology and
treatment guidelines as well as an overview on the competitive
landscape
• Detailed information on the key drugs in India including product
description, safety and efficacy profiles as well as a SWOT analysis
• Sales forecast for the top drugs in India from 2012-2022
• Analysis of the impact of key events as well the drivers and restraints
affecting India NSCLC market
Report Coverage
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
• Understand and capitalize by identifying products that are most likely
to ensure a robust return
• Stay ahead of the competition by understanding the changing
competitive landscape for NSCLC
• Effectively plan your M&A and partnership strategies by identifying
drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth
analysis of drug performance
• Obtain sales forecast for drugs from 2012-2022 in India
Report Benefits
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
Table of Contents
• Introduction
• Disease Overview
• Disease Management
• Competitive Assessment
• Opportunity and Unmet Need
• Pipeline Assessment
• Market Outlook
• Appendix
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
List of Figures and Tables
Figures:
• Competitive Assessment of Late-Stage Pipeline Agents in NSCLC, 2012-2022 • Sales for NSCLC in India by Drug, 2012-2022
Tables:
• Symptoms of Disease • Treatment Guidelines for NSCLC • Stage Definitions for NSCLC • Treatment Overview by Stage of Diagnosis for NSCLC • Leading Treatments for NSCLC • Product Profile - Alimta (pemetrexed disodium) • Alimta SWOT Analysis, 2013 • Product Profile - Iressa (gefitinib) • Iressa SWOT Analysis, 2013 • Product Profile - Tarceva (erlotinib hydrochloride)
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
List of Figures and Tables (Continued)
• Tarceva SWOT Analysis, 2013 • Product Profile - Xalkori (crizotinib) • Xalkori SWOT Analysis, 2013 • Product Profile - Avastin (bevacizumab) • Avastin SWOT Analysis, 2013 • Overall Unmet Needs - Current Level of Attainment • Clinical Unmet Needs - Gap Analysis, 2013 • Non-Small Cell Lung Cancer - Phase I-II Pipeline, 2013 • NSCLC - Phase III Pipeline, 2013 • NSCLC - Advantages and Disadvantages of Therapeutic Classes • Product Profile - nintedanib (BIBF-1120) • nintedanib SWOT Analysis, 2013 • Product Profile - Gilotrif (afatinib) • Gilotrif SWOT Analysis, 2013 • Product Profile - dacomitinib (PF-00299804) • dacomitinib SWOT Analysis, 2013
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
List of Figures and Tables (Continued)
• Product Profile - LDK378 • LDK378 SWOT Analysis, 2013 • Sales Forecasts ($m) for NSCLC in India, 2012-2022 • Key Events Impacting Sales for NSCLC in India, 2012-2022 • NSCLC Market in India - Drivers and Barriers, 2012-2022 • Five Year Prevalence • Key Launch Dates • Physicians Surveyed by Country
Report: PharmaPoint Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
www.researchonglobalmarkets.com
Interested in this report?
About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports
For further information, get in touch with us:
E-mail: [email protected] Call: International: +91 (22) 4098 7600
Industry Segments
Automotive & Transport Consumer goods Agriculture
Food and Beverage Energy and Utilities Public Sector
Manufacturing & Construction Healthcare Media & Entertainment
IT, Telecom & Electronics Services Others
To view more details regarding this premium market research report, Please click here
